FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype (Q91535153)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

title

FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Nolan Priedigkeit

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Ahmed Basudan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Nilgun Tasdemir

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Ethan S Sokol

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Ryan J Hartmaier

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Kai Ding

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Nedah Z Ahmad

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Rebecca J Watters

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Kurt R Weiss

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Jens-Uwe Blohmer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Carsten Denkert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Anna Machleidt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Maria M Karsten

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Michelle M Boisen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Esther Elishaev

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Peter C Lucas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

publication date

27 June 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

page(s)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials

23 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

Exome-capture RNA sequencing of decade-old breast cancers and matched decalcified bone metastases

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable Targets.

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

Frequent ESR1 and CDK Pathway Copy Number Alterations in Metastatic Breast Cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

Integrative clinical genomics of metastatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis.

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534).

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

FGFR4 provides the conduit to facilitate FGF19 signaling in breast cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

FGFR4 phosphorylates MST1 to confer breast cancer cells resistance to MST1/2-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

Loss of E-cadherin Enhances IGF1-IGF1R Pathway Activation and Sensitizes Breast Cancers to Anti-IGF1R/InsR Inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

E-cadherin loss induces targetable autocrine activation of growth factor signalling in lobular breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

Advances and challenges in targeting FGFR signalling in cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor.

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

LY2874455 potently inhibits FGFR gatekeeper mutants and overcomes mutation-based resistance

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

Genomic profiling of ER+ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance.

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

Association of FGFR1 with ERαmaintains ligand-independent ER transcription and mediates resistance to estrogen deprivation in ER+ breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

Salmon provides fast and bias-aware quantification of transcript expression

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

Exploring genomic alteration in pediatric cancer using ProteinPaint

1 reference

https://api.crossref.org/works/10.1038%2FS41523-019-0114-X

7 January 2021

10.1038/S41523-019-0114-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

PubMed publication ID

31263748

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31263748%20AND%20SRC:MED&resulttype=core&format=json